Search

everythinglearnresearchcommunity

for

Search:↓

PrEP for HIV is less effective in transgender women mainly due to low adherence to the treatment.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Two women with very high androgen levels had only slight skin issues, one due to a non-classical adrenal disorder and the other due to an adrenal tumor.

Adult female acne is a complex condition that can worsen with menopause, requiring holistic treatment and tailored skincare at different life stages.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Spironolactone is an effective and well-tolerated first-line treatment for hidradenitis suppurativa in women.

The document concludes that managing non-classical congenital adrenal hyperplasia in females requires personalized treatment, genetic counseling, and a team of specialists.

Ovarian SAHA syndrome makes women with PCOS more resistant to insulin and increases their risk of blood sugar problems.

Hormone therapy in transgender women can affect hair growth and acne, and there are specific skin issues related to gender-affirming surgery, but more research is needed on their dermatological health.

Younger transgender women have surgery earlier, are mostly attracted to men, and show more preoperative depression that improves after surgery compared to older transgender women.

Diagnose and manage hair issues in women by checking medical conditions and using personalized treatments.

Hyperandrogenism increases heart disease risk in premenopausal women, but this risk is linked to obesity in postmenopausal women.

Genetic mutations can affect female sexual development, requiring personalized medical care.

The document concludes that skin aging in women can be caused by UV exposure and hormonal changes, and treatments like hormone replacement therapy and various skin therapies can help.

High androgen levels in young women with PCOS are linked to higher blood pressure.

Zinc is crucial for growth and health in rats.

Spironolactone effectively reduces hair growth in women with hirsutism and is generally well-tolerated.

Finasteride reduces hairiness and androgen levels in women with unexplained excessive hair growth.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Testosterone and dihydrotestosterone play a role in women's health issues like excess hair and baldness, and treatments blocking these hormones may help.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Finasteride improves hair growth and reduces hirsutism in women, but side effects and optimal dosages need further research.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Some skin medications are safe for pregnant women, but others pose risks or should not be used.

Some epilepsy drugs can cause reproductive and cosmetic side effects in women and affect pregnancy, but most women still have healthy babies.

Finasteride helps induce ovulation in nonresponder PCOS women.